August 01, 2025 a 09:01 am
TMO: Analysts Ratings - Thermo Fisher Scientific Inc.
Thermo Fisher Scientific Inc. has shown consistent performance with predominately positive analyst ratings. The company's diverse portfolio in life sciences solutions, diagnostic instruments, and laboratory products positions it as a market leader with strong buy recommendations from analysts. However, while the buy ratings remain high, there is a notable trend towards more hold positions in recent months, suggesting a cautious optimism among analysts.
Historical Stock Grades
The analysis of analyst ratings over recent months reveals a robust preference towards buy recommendations with a slight shift towards holding positions. The latest data from July 2025 highlights a maintained confidence with numerous buy and strong buy ratings.
| Recommendation | Number | Score |
|---|---|---|
| Strong Buy | 8 | |
| Buy | 18 | |
| Hold | 7 | |
| Sell | 0 | |
| Strong Sell | 0 |
Sentiment Development
Recent months have shown stable analyst sentiment, with buy ratings maintaining dominance. The overall number of ratings has seen a slight uptick, potentially due to increased market activity. Trends indicate:
- A consistent strong buy sentiment over the last year.
- A slight increase in hold ratings, reflecting some cautiousness in the market.
- Steady or declining strong buy ratings with no emergence of sell ratings.
Percentage Trends
Over the past year, there has been a subtle shift in analyst sentiment with a minor increase in hold ratings, potentially signaling caution. This trend has been offset by stable strong buy ratings and a decline in strong buy percentages. Noteworthy points include:
- Stable strong buy ratings showcasing sustained confidence.
- Slight increase in hold percentage indicating careful market optimism.
- Absence of strong sell opinions strengthens the positive market outlook.
In the last 6-12 months, the most noticeable change is the resilience of the buy ratings coupled with a gradual rise in holds, an indicator of market uncertainty or reevaluation.
Latest Analyst Recommendations
Recent analyst recommendations have primarily seen a maintenance of current ratings, suggesting a stable market outlook for Thermo Fisher Scientific Inc. The following table showcases recent analyst actions:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-07-24 | Neutral | Neutral | UBS |
| 2025-07-24 | Outperform | Outperform | Raymond James |
| 2025-07-24 | Overweight | Overweight | Wells Fargo |
| 2025-07-24 | Equal Weight | Equal Weight | Barclays |
| 2025-07-24 | Outperform | Outperform | Baird |
Analyst Recommendations with Change of Opinion
Some recent recommendations have involved changes of opinion, reflecting shifts in analyst sentiment. The following table details these changes:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-07-11 | Sector Outperform | Sector Perform | Scotiabank |
| 2025-07-09 | Neutral | Buy | UBS |
| 2024-01-24 | Equal Weight | Overweight | Barclays |
| 2024-01-08 | Market Perform | Outperform | Bernstein |
| 2023-10-26 | Sector Weight | Overweight | Keybanc |
Interpretation
The market sentiment surrounding Thermo Fisher Scientific Inc. remains largely positive with a steady stream of buy recommendations. The slight increase in hold opinions may indicate a market re-evaluation or strategic caution. The seeming steadiness of strong buy suggestions and lack of strong sell ratings suggest continued confidence in TMO's market positioning. These factors indicate a balanced perspective with analysts maintaining a cautiously optimistic view of TMO's future.
Conclusion
Thermo Fisher Scientific Inc. continues to command solid analyst support with overwhelming buy and strong buy ratings. While added hold ratings suggest an element of caution, there is no significant shift towards bearish sentiment. Analysts appear to endorse the company's market strategy and robust business model, which mitigates risk and captures growth opportunities. Moving forward, TMO holds a promising outlook but long-term investors may consider monitoring any shifts in industry dynamics or increased competitive pressures. The sustained analyst confidence underscores TMO's market resilience and potential for stable growth.